Apathy: Neurobiology, Assessment and Treatment
Clinical Psychopharmacology and Neuroscience
;
: 181-189, 2021.
Artigo
em Inglês
| WPRIM
| ID: wpr-890218
ABSTRACT
Apathy is a highly prevalent, disabling and treatment resistant syndrome. It is defined as a quantitative reduction of goaldirected activity in comparison to the patient’s previous level of in multiple dimensions including behavior/cognition, emotion and social interaction. It has been described in major depressive disorder, Alzheimer’s disease, frontotemporal dementia, Parkinson’s Disease, cerebrovascular disease, and vascular dementia, among others. This review will address the neuropsychology and associated neurobiological underpinnings of apathy in the above conditions, identify specific methods to assess apathy clinically, and review the literature on managing apathy across these various disorders.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Inglês
Revista:
Clinical Psychopharmacology and Neuroscience
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS